🔴 Chimeric Therapeutics is trading 15.38% down today

Chimeric Therapeutics is trading 15.38% down at A$0.01, with no clear company-specific announcement identified on August 27, 2026.

• The latest major update, dated August 19, 2026, said CHM-2101 enrolment and dosing stopped following dose-limiting toxicities.
• Biotech sentiment was positive, while the company-specific move was negative.
• Confidence in the catalyst remains low.